Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity

Oncogene
M UeffingW Kolch

Abstract

Several observations indicate that the Raf-1 kinase is a downstream effector of protein kinase C-epsilon (PKC epsilon). We recently have shown that Raf-1 is constitutively activated in PKC epsilon transformed Rat6 fibroblasts, and transformation can be reverted by expression of a dominant negative Raf-1, but not a dominant negative Ras mutant (Cacace et al., 1996). Cai et al. (1997) demonstrated that PKC epsilon induced proliferation of NIH3T3 cells is independent of Ras or Src, but depends on Raf-1. These authors further suggested that PKC epsilon activates Raf-1 by direct phosphorylation. Here we have investigated the functional interaction between PKC epsilon and Raf-1. PKC epsilon, but not PKC alpha, was found to bind to the Raf-1 kinase domain. The association appeared to be direct, as it could be reconstituted in vitro with purified proteins. Raf-1 and PKC epsilon could be co-precipitated from Sf-9 insect cells and PKC epsilon transformed NIH313 cells (NIH/epsilon). The association was negatively regulated by ATP in vitro and by TPA treatment in NIH/epsilon cells, but not in Sf-9 insect cells. Raf-1 was constitutively activated in NIH/epsilon cells. However, using coexpression experiments in Sf-9 cells and transiently tra...Continue Reading

Citations

Apr 23, 2002·Journal of Cellular Biochemistry·Souvenir D TachadoDavid M Terrian
Apr 15, 2010·Archives of Environmental Contamination and Toxicology·Abraham B AbrahaMargaret M Whalen
Nov 19, 2003·Biochemical and Biophysical Research Communications·Michael LeeWayne B Anderson
May 5, 2001·Pharmacology & Therapeutics·C R Weinstein-OppenheimerJ A McCubrey
Mar 4, 2000·Free Radical Biology & Medicine·R G Allen, M Tresini
Mar 19, 2002·Cellular Signalling·Karen EnglandMartin Rumsby
Aug 25, 2001·Annual Review of Neuroscience·M V SofroniewW C Mobley
Jun 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nikos Tapinos, Anura Rambukkana
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·M LinariJ Becker
Jun 1, 2008·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Michael Lee
Sep 28, 2013·FEBS Letters·Ni ZhangLijun Xu
May 17, 2007·Expert Opinion on Therapeutic Targets·Amalia MilanoFrancesco Caponigro
Sep 5, 2009·Chronobiology International·Fernanda Pizão FarhatAna Maria De Lauro Castrucci
Mar 29, 2011·Pharmacological Reports : PR·Ewa TotońMaria Rybczyńska
Nov 26, 2008·Biochemical and Biophysical Research Communications·Yahong ZhangTakashi Ikejima
Jul 28, 2004·British Journal of Pharmacology·Fernando MagroPatrício Soares-da-Silva
Mar 5, 2013·International Journal of Cancer. Journal International Du Cancer·Xiaoping ZhangZhongwei Lv
Feb 19, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Bang-Jau YouHong-Zin Lee
May 2, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Piotr JasinskiArkadiusz Z Dudek
Sep 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Muralidhar BeeramEric K Rowinsky
Sep 17, 2005·Blood·Prisco MirandolaMarco Vitale
May 19, 2001·The Journal of Biological Chemistry·M HamiltonA Wolfman
Dec 5, 1998·The Journal of Biological Chemistry·X S XuB P Monia
Sep 9, 2006·The Journal of Pharmacology and Experimental Therapeutics·Esther P JaneIan F Pollack

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.